Literature DB >> 35499799

Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Authors' Reply.

Nitin Dhochak1, Rakesh Lodha2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35499799      PMCID: PMC9059437          DOI: 10.1007/s12098-022-04204-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


× No keyword cloud information.
To the Editor: We thank Mandal et al. for their interest in our report and insightful comments on our findings and summary of mechanisms for better immunity against SARS-CoV-2 in children with CF [1, 2]. It was suggested that prolonged and repeated viral PCR positivity in our patients is likely due to prolonged viral shedding. Prolonged shedding has been described in literature, and limited studies where culture has been attempted for prolonged PCR positivity, suggest that virus is probably nonviable [3]. However, risk of prolonged shedding is more in older patients and least in children, and mostly, prolonged shedding has been described in asymptomatic patients. Recurrent infections of SARS-CoV-2 have been well reported with symptomatic disease [4]. Both of our patients had severe symptoms during the first two episodes. Since we did not perform viral culture and strain identification during the episodes, it is difficult to conclude with confidence whether the episodes were persistent/reinfection or there was prolonged shedding. Mandal et al. have suggested that COVID-19 is mild in children with CF [1]. We do not fully agree with that notion. Though initial reports of COVID-19 in CF patients suggested that the disease may not be as severe as expected, these reports were from developed countries and before the period of delta variant [5]. A recent large prospective series of Italian cohort of 236 CF patients had 18% hospitalizations and 2.5% mortality, which is significantly higher than the general population of similar age group (median age 25 y) [6]. Risk factors of severe COVID-19 amongst the cohort were low FEV1 predicted (< 40%), home oxygen support, underweight, organ transplant, diabetes, and liver disease; while the use of dornase alpha and long-term azithromycin were associated with reduced risk [6]. Children with CF in India are frequently malnourished, and have low lung function, which places them at high risk for severe COVID-19 [7]. Both the patients in our series had poor lung health and case 1 had severe malnutrition.
  7 in total

1.  Predictors of Malnutrition in Children with Cystic Fibrosis.

Authors:  Nitin Dhochak; Kana Ram Jat; Jhuma Sankar; Rakesh Lodha; Sushil K Kabra
Journal:  Indian Pediatr       Date:  2019-08-10       Impact factor: 1.411

2.  SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.

Authors:  Muge Cevik; Matthew Tate; Ollie Lloyd; Alberto Enrico Maraolo; Jenna Schafers; Antonia Ho
Journal:  Lancet Microbe       Date:  2020-11-19

3.  Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.

Authors:  Letícia Adrielle Dos Santos; Pedro Germano de Góis Filho; Ana Maria Fantini Silva; João Victor Gomes Santos; Douglas Siqueira Santos; Marília Marques Aquino; Rafaela Mota de Jesus; Maria Luiza Dória Almeida; João Santana da Silva; Daniel M Altmann; Rosemary J Boyton; Cliomar Alves Dos Santos; Camilla Natália Oliveira Santos; Juliana Cardoso Alves; Ianaline Lima Santos; Lucas Sousa Magalhães; Emilia M M A Belitardo; Danilo J P G Rocha; João P P Almeida; Luis G C Pacheco; Eric R G R Aguiar; Gubio Soares Campos; Silvia Inês Sardi; Rejane Hughes Carvalho; Amélia Ribeiro de Jesus; Karla Freire Rezende; Roque Pacheco de Almeida
Journal:  J Infect       Date:  2021-02-13       Impact factor: 6.072

4.  Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.

Authors:  Hannah R Mathew; May Y Choi; Michael D Parkins; Marvin J Fritzler
Journal:  BMC Pulm Med       Date:  2021-05-20       Impact factor: 3.317

5.  Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis.

Authors:  Nitin Dhochak; Kana Ram Jat; Kapil Dev Soni; Yudhyavir Singh; Richa Aggarwal; Rakesh Lodha; Anjan Trikha; Sushil K Kabra
Journal:  Indian J Pediatr       Date:  2022-01-28       Impact factor: 5.319

6.  Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Correspondence.

Authors:  Mohanchandra Mandal; Susanta Sarkar; Antonio M Esquinas
Journal:  Indian J Pediatr       Date:  2022-04-11       Impact factor: 5.319

7.  Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.

Authors:  Carla Colombo; Marco Cipolli; Valeria Daccò; Paola Medino; Federico Alghisi; Maura Ambroni; Raffaele Badolato; Fiorella Battistini; Elisabetta Bignamini; Rosaria Casciaro; Fabiana Ciciriello; Mirella Collura; Isabella Comello; Michela Francalanci; Francesca Ficili; Anna Folino; Salvatore Leonardi; Giuseppina Leonetti; Maria Cristina Lucanto; Francesca Lucca; Massimo Maschio; Valeria Mencarini; Barbara Messore; Giovanna Pisi; Giovanna Pizzamiglio; Piercarlo Poli; Valeria Raia; Luca Riberi; Mirco Ros; Novella Rotolo; Angela Sepe; Giovanni Taccetti; Pamela Vitullo; Gianfranco Alicandro
Journal:  Infection       Date:  2021-12-07       Impact factor: 7.455

  7 in total
  1 in total

1.  Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Correspondence.

Authors:  Mohanchandra Mandal; Susanta Sarkar; Antonio M Esquinas
Journal:  Indian J Pediatr       Date:  2022-04-11       Impact factor: 5.319

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.